KYTX

Kyverna Therapeutics, Inc. Common Stock
Data: 2026-01-30
$8.01
Price
-3.17%
Change
$13.67
52W High
$1.78
52W Low

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

Quick Stats
Jan 30, 2026

54.2

AI Score

HOLD

0.73

Volume Ratio

Next Earnings

15

+ve Days (30d)

15

-ve Days (30d)

KYTX Stock Summary

Last updated Jan 30, 2026

KYTX is currently trading at $8.01, positioned above its 200-day moving average of $5.2, indicating a long-term uptrend. The stock has a 52-week range of $1.78 to $13.67.

Technical Analysis: The 50-day moving average stands at $8.39, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 44.889, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.051, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates KYTX at 54.2/100 with a HOLD recommendation.

KYTX (Kyverna Therapeutics, Inc. Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 44.889
CMF (20) -0.051
ROC (10) -8.142
ADX (14) 16.868
Indicator Value
MACD (12,26,9) 0.064
AROONOSC (14) -42.857
WILLAMS %R (14) -88.042
MFI (14) 49.039
KYTX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

KYTX Price vs Max Options Open Interest
KYTX Max Change In Options Open Interest

KYTX Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

KYTX Daily Out of Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

KYTX Daily In the Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

KYTX Most Active Options by Volume(near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Kyverna Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

KYTX Moving Averages Analysis

Kyverna Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026

KYTX (Kyverna Therapeutics, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 8.98
20 8.75
30 8.66
50 8.39
100 7.33
200 5.2

KYTX Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 499.5 million
Earnings/Share ($) -3.73
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -3.7055
EPS Estimate Next Year ($) -3.407
WallStreet Target Price ($) 29.6
Most Recent Quarter